Status:
ENROLLING_BY_INVITATION
Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients
Lead Sponsor:
China Medical University Hospital
Conditions:
Chronic Kidney Diseases
Proteinuria
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The single center, randomized, assessor- and participant-blind, controlled, cross-over on-venous laser irradiation of blood clinical trial was performed to analyze patients with DKD. The information w...
Detailed Description
Microalbuminuria is the cardinal symptom of diabetes kidney disease (DKD) and is linked to renal function decline. The cardiovascular risk of patients with DKD is much higher than that of the general ...
Eligibility Criteria
Inclusion
- HbA1C≥6.5 % and ≤ 9%, ±0.5% under past three months
- eGFR ≥30ml/min/1.73m2 and protinuria ≥30mg/d under ACEI or ARB treatment
Exclusion
- allergic to laser beans
- Immunosuppressive drugs had been used in the past six months
- urine protein over 3.5 g /day
- Autosomal dominant polycystic kidney disease
- Lupus nephritis
- People with mental illness or other mental disabilities are unable to cooperate with the researcher.
- Those who used non-steroidal analgesics and steroids in the trial period
- Pregnant or lactating women
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06588465
Start Date
July 1 2024
End Date
December 31 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, North Dist, Taiwan, 404